GlassScriptPhysician profile
Robin V Suess
NPI 1063798353
$1,895.73
in general payments reported to CMS, 2019-2025
19 companies · $1,403 in 2025
The $1,403 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.84 · 2022: $403 · 2023: $27.47 · 2025: $1,403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,403 · Food and Beverage: $27.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,402.50 |
| Food and Beverage | $27.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,402.50 | 2025 | |
| Celgene Corporation | $79.99 | 2022 | |
| Genzyme Corporation | $49.92 | 2022 | |
| Aveo Pharmaceuticals, INC. | $39.52 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $36.15 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $27.47 | 2023 | Opdualag |
| Seagen INC. | $26.93 | 2022 | |
| Amgen INC. | $25.00 | 2022 | |
| Glaxosmithkline, LLC. | $24.17 | 2021 | |
| Merck Sharp & Dohme LLC | $21.83 | 2021 | |
| Astellas Pharma US INC | $21.75 | 2022 | |
| Janssen Biotech, INC. | $19.97 | 2022 | |
| Daiichi Sankyo INC. | $19.42 | 2022 | |
| Array Biopharma INC | $19.11 | 2022 | |
| Foundation Medicine, INC. | $18.33 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eusa Pharma (US) LLC | $18.32 | 2022 | |
| Adc Therapeutics America, INC. | $16.84 | 2021 | |
| Puma Biotechnology, INC. | $15.63 | 2022 | |
| Pfizer INC. | $12.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Suess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.